STEPHEN HARDING to Monoclonal Gammopathy of Undetermined Significance
This is a "connection" page, showing publications STEPHEN HARDING has written about Monoclonal Gammopathy of Undetermined Significance.
Connection Strength
0.191
-
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. Lancet Haematol. 2022 May; 9(5):e340-e349.
Score: 0.191